Skip to main content
OpenTrials

Clinical trial condition

Primary hyperoxaluria type 1

Explore clinical trials studying Primary hyperoxaluria type 1. Study availability and eligibility vary by location and protocol.

20 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Primary hyperoxaluria type 1 trial results

Recruiting

Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)

NCT06839235

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +13 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • Nucleus Network Saint Paul, Minnesota, United States
  • Hospices Civils de Lyon- Hôpital Femmes Mères Enfants Lyon, France
  • Kindernierenzentrum Bonn Bonn, Germany
View Trial Details
Recruiting

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

NCT04580420

Conditions
Chronic Disease, Disease Attributes, End Stage Renal Disease, +13 more
Locations
  • Clinical Trial Site San Francisco, California, United States
  • Clinical Trial Site Boston, Massachusetts, United States
  • Clinical Trial Site Rochester, Minnesota, United States
  • Clinical Trial Site New York, United States
View all 18 locations
View Trial Details
Recruiting

Retrospective and Prospective Follow-up of Patients With Primary Hyperoxaluria Type 1 Treated With Lumasiran in France.

NCT06225882

Conditions
Patients With PH1 Treated With Lumasiran in France, Primary hyperoxaluria type 1
Locations
  • CHU de Besançon Besançon, France
  • Centre de Référence des Maladies Rénales Rares - Hospices Civils de Lyon - Service de Néphrologie et Rhumatologie Pédiatriques - Hôpital Femme Mère Enfant Bron, France
  • Hopital Edouard Herriot Lyon, France
  • AP-HM - Timone Enfants Marseille, France
View Trial Details
Active, not recruiting

Early Check: Expanded Screening in Newborns

NCT03655223

Conditions
17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations
  • RTI International Research Triangle Park, North Carolina, United States
View Trial Details
Active, not recruiting

BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)

NCT04982393

Conditions
Primary Hyperoxaluria Type 1, Primary hyperoxaluria type 1
Locations
  • Clinical Trial Site Phoenix, Arizona, United States
  • Clinical Trial Site Washington D.C., District of Columbia, United States
  • Clinical Trial Site Boston, Massachusetts, United States
  • Clinical Trial Site Rochester, Minnesota, United States
View all 30 locations
View Trial Details

Related conditions